Whatisthe bestcapitalforyourbusiness?
An interactive and personalized analysis to navigate the universe of funding instruments — from debt to equity, from seed to IPO — considering your company's stage and current market conditions.
Selic at 15%
The cost of third-party capital is at its highest level in years. Every financing decision directly impacts the bottom line.
IPO Drought
B3 has not registered an IPO since 2021. Over 50 companies await the window to reopen, while others migrate to international listings.
Disciplined VC
Venture Capital funds are more selective, prioritizing efficiency and unit economics over growth at any cost.
Capital Universe
Pathways to fund your growth
Explore the main categories of instruments available in the Brazilian and international markets.
Equity — Share Capital
Investors acquire a stake in the company in exchange for capital. Ranges from angel investors to stock exchange IPOs. The cost is founder dilution, but it brings Smart Money — experience, networking, and credibility.
Debt — Third-Party Capital
Credit instruments where the company commits to repaying capital plus interest. No dilution, but requires repayment capacity and often real guarantees. With Selic at 15%, the cost is historically high.
Hybrids — Best of Both Worlds
Instruments combining debt and equity features, such as convertible notes and mezzanine. They offer flexibility for both parties and are especially useful during valuation uncertainty. Non-traditional capital sources such as crowdfunding, government grants, revenue-based financing, and bootstrapping. They democratize access to capital and offer creative alternatives.
Interactive Diagnostic
Discover the ideal capital for you
Answer 5 questions about your business and receive a personalized recommendation of funding instruments.
Maturity Stage
What stage is your business at?
Legal Notice — Disclaimer
The information and recommendations provided by this tool are based on theoretical corporate finance models and public market data. They are purely educational and informational in nature, and do not constitute, under any circumstances, an investment recommendation, legal or tax advice, or securities offering under CVM regulations. The final decision on fundraising should be made after thorough analysis with your own financial, legal, and accounting advisors, considering the specifics of your business and the prevailing regulatory environment. Vectora Lab Capital disclaims any liability for decisions made based on the information presented here. Market data as of March 2026.